2/2
08:00 am
nspr
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
1/20
09:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/12
09:00 am
nspr
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
Medium
Report
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
1/10
07:02 pm
nspr
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago [Yahoo! Finance]
Medium
Report
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago [Yahoo! Finance]
11/24
07:30 am
nspr
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
Low
Report
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
11/21
10:25 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/21
09:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/19
04:41 pm
nspr
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
High
Report
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference